Ecolab
ECL
$277.63
-0.61%
Ecolab is a global leader in cleaning, sanitation, and water management solutions, serving industries such as industrial manufacturing, hospitality, healthcare, and life sciences. As the dominant market share player in its category, it differentiates itself through a comprehensive portfolio of products and services, including pest control and infection prevention. The current investor narrative centers on Ecolab's strategic pivot into the high-growth AI data center cooling market, highlighted by its $4.75 billion acquisition of CoolIT, which has sparked debate about the price and timing of the deal. Meanwhile, the company continues to deliver steady revenue growth and margin expansion, though near-term stock performance has been pressured by skepticism around the acquisition's execution.…
ECL
Ecolab
$277.63
Investment Opinion: Should I buy ECL Today?
Rating: Hold. Ecolab is a high-quality company with accelerating growth and strong margins, but its premium valuation and acquisition risks warrant caution. The analyst consensus is Buy with an average target of $319.43, implying 18.9% upside, but the stock's recent underperformance and range-bound technicals suggest near-term uncertainty.
Supporting Evidence: Revenue grew 10.0% YoY in Q1 2026, accelerating from 8.7% in Q4 2025. Gross margin of 43.6% and operating margin of 15.3% demonstrate pricing power and operational efficiency. Free cash flow of $1.87 billion supports dividends and debt reduction. The forward P/E of 28.7x implies expected earnings growth of 20% over the next year, which is achievable if the CoolIT acquisition contributes. However, the trailing P/E of 35.8x is well above the industry average of 22x, leaving limited margin of safety.
Risks & Conditions: The Hold rating could upgrade to Buy if the stock pulls back to the $250 level (near 52-week low) or if CoolIT integration shows clear margin benefits in the next two quarters. It would downgrade to Sell if revenue growth decelerates below 5% or if debt-to-equity rises above 1.2. Overall, Ecolab is fairly valued relative to its history (P/E near midpoint of 5-year range) but overvalued relative to industry peers. The stock offers a reasonable risk/reward for long-term investors willing to tolerate near-term volatility.
Sign up to view all
ECL 12-Month Price Forecast
Ecolab's fundamentals are solid with accelerating revenue and strong margins, but the premium valuation and acquisition risks create uncertainty. The stock's underperformance vs the market suggests skepticism that is not fully priced in. The base case of steady growth to $319 is most likely, but the wide target range ($275-$345) reflects high uncertainty. We would turn more bullish if the stock pulls back to $250 or if CoolIT integration shows clear progress. A downgrade to bearish would occur if revenue growth dips below 5% or margins contract significantly.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ecolab's 12-month outlook, with a consensus price target around $324.67 and implied upside of +16.9% versus the current price.
Average Target
$324.67
0 analysts
Implied Upside
+16.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$295 - $360
Analyst target range
Ecolab is covered by 21 analysts, with a consensus recommendation of 'Buy' (mean rating 1.65 on a 1-5 scale). The average target price is $319.43, implying 18.9% upside from the current price of $268.75. The distribution shows 16 Buy, 4 Hold, and 1 Sell, reflecting strong bullish sentiment. The target range spans from $275 (low) to $345 (high), with the low implying 2.3% upside and the high implying 28.4% upside. The wide spread of $70 indicates significant uncertainty about the company's future, likely due to the CoolIT acquisition integration and macroeconomic headwinds. Recent analyst actions include upgrades from UBS (Neutral to Buy) and reaffirmations from Deutsche Bank and RBC Capital, suggesting growing confidence. The high target of $345 likely assumes successful AI cooling expansion and margin expansion, while the low target prices in integration risks and slower growth.
Drowning in data?
Find the real signal!
Bulls vs Bears: ECL Investment Factors
Ecolab presents a balanced risk/reward profile. On the bull side, accelerating revenue growth (10% YoY), strong margins, and a strategic pivot into AI cooling via CoolIT offer upside potential. The analyst consensus Buy with 18.9% upside supports this view. However, bears point to a premium valuation (35.8x P/E vs 22x industry), integration risks from the large acquisition, and persistent underperformance vs the market. The single most important tension is whether the CoolIT acquisition will successfully accelerate growth and margins enough to justify the premium valuation. If integration goes smoothly, the stock could re-rate higher; if not, multiple compression could erase gains.
Bullish
- Accelerating Revenue Growth: Q1 2026 revenue grew 10.0% YoY to $4.066 billion, accelerating from 8.7% in Q4 2025. This marks the fastest growth in recent quarters, driven by strength in Global Water and the CoolIT acquisition.
- Strong Margin Expansion: Operating margin improved to 15.3% in Q1 2026 from 15.9% a year ago, while net margin held at 10.6%. Gross margin of 43.6% reflects pricing power and cost controls, supporting profitability.
- Healthy Free Cash Flow: Trailing twelve-month free cash flow stands at $1.87 billion, providing ample capacity for dividends and strategic acquisitions. This financial flexibility reduces reliance on debt for growth initiatives.
- Analyst Consensus Buy: 21 analysts rate ECL a Buy with a mean target of $319.43, implying 18.9% upside. Recent upgrades from UBS and reaffirmations from Deutsche Bank and RBC Capital indicate growing confidence.
Bearish
- Premium Valuation vs Peers: Trailing P/E of 35.8x is 63% above the specialty chemicals industry average of 22x. While justified by growth, any earnings miss could trigger multiple compression.
- CoolIT Acquisition Risks: The $4.75 billion price tag is significant, and integration risks could weigh on near-term margins. Skepticism around the deal has contributed to the stock's 0.4% decline over the past year.
- Underperformance vs S&P 500: ECL has underperformed the S&P 500 by 16.9% over the past year, with a 1-year price change of -0.4%. This persistent relative weakness suggests market skepticism.
- Elevated Debt Levels: Debt-to-equity of 0.97 is moderate but elevated for a company making a large acquisition. Interest expense of $72.7 million in Q1 2026 could pressure earnings if rates stay high.
ECL Technical Analysis
Ecolab's stock is in a range-bound consolidation phase, with a 1-year price change of -0.4% reflecting a lack of clear directional trend. The current price of $268.75 sits at 46% of the 52-week range ($243.15-$309.27), indicating it is closer to the low end and potentially offering a value opportunity if fundamentals support a recovery. The stock has underperformed the S&P 500 significantly over the past year, with relative strength of -16.9%, suggesting persistent selling pressure relative to the broader market. Over the past 1 month, the stock declined 2.7%, while the 3-month change is -0.3%, showing a deceleration in the downtrend compared to the 1-year decline. This divergence could signal a potential bottoming process, but the 1-month relative strength of -3.5% versus the S&P 500 indicates continued weakness. The stock's beta of 0.895 implies slightly lower volatility than the market, which may appeal to risk-averse investors but also limits upside participation in rallies. The 52-week high of $309.27 acts as key resistance, while the 52-week low of $243.15 provides support. A breakout above $309 could signal a trend reversal, while a breakdown below $243 would suggest further downside. The short ratio of 1.9 days indicates moderate bearish sentiment but not extreme positioning.
Beta
0.90
0.90x market volatility
Max Drawdown
-20.3%
Largest decline past year
52-Week Range
$243-$309
Price range past year
Annual Return
+6.1%
Cumulative gain past year
| Period | ECL Return | S&P 500 |
|---|---|---|
| 1m | -0.3% | +0.2% |
| 3m | +7.0% | +3.7% |
| 6m | -1.5% | +8.0% |
| 1y | +6.1% | +18.2% |
| ytd | +5.7% | +9.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ECL Fundamental Analysis
Ecolab's revenue trajectory remains solidly positive, with Q1 2026 revenue of $4.066 billion, up 10.0% year-over-year, accelerating from the 8.7% growth in Q4 2025. The Global Water segment, the largest at $2.043 billion, is a key growth driver, while the Global Institutional and Specialty segment contributed $1.511 billion. The CoolIT acquisition is expected to further boost revenue in the AI cooling space, though it adds execution risk. Net income for Q1 2026 was $432.6 million, with a net margin of 10.6%, up from 10.9% in the prior year quarter, indicating improving profitability. Gross margin expanded to 43.6% from 44.3% a year ago, reflecting pricing power and cost controls. Operating margin improved to 15.3% from 15.9% in Q1 2025, showing steady operational efficiency. The company maintains a healthy balance sheet with a debt-to-equity ratio of 0.97, moderate leverage, and a current ratio of 1.08, indicating adequate liquidity. Free cash flow for the trailing twelve months was $1.87 billion, providing ample capacity for dividends and strategic acquisitions. ROE stands at 21.2%, demonstrating strong returns on shareholder equity.
Quarterly Revenue
$4.1B
2026-03
Revenue YoY Growth
+10.0%
YoY Comparison
Gross Margin
43.5%
Latest Quarter
Free Cash Flow
$1.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ECL Overvalued?
Given positive net income, we use the P/E ratio as the primary valuation metric. The trailing P/E is 35.8x, while the forward P/E is 28.7x, implying the market expects earnings growth to justify the current price. The gap between trailing and forward P/E suggests a 20% expected earnings increase over the next year. Compared to the specialty chemicals industry average P/E of 22x, Ecolab trades at a 63% premium, reflecting its market leadership and growth prospects. The premium is partially justified by superior margins and ROE, but it leaves little room for error. Historically, Ecolab's trailing P/E has ranged from 24x to 74x over the past five years, with the current 35.8x near the midpoint. This suggests the stock is not excessively overvalued relative to its own history, but it is not cheap either. The P/B ratio of 7.6x is elevated, indicating the market values its intangible assets and brand strength.
PE
35.8x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 25x~56x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
24.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Ecolab's debt-to-equity ratio of 0.97 is moderate, but the $4.75 billion CoolIT acquisition adds leverage and integration risk. Interest expense of $72.7 million in Q1 2026 could pressure net income if rates remain elevated. The company's net margin of 10.6% is solid but could be squeezed by higher costs or integration expenses. Free cash flow of $1.87 billion provides a buffer, but any disruption in cash generation could strain the balance sheet. Revenue concentration in the Global Water segment (50% of total) also poses a risk if that market slows.
Market & Competitive Risks: Ecolab trades at a 63% premium to the specialty chemicals industry average P/E, leaving it vulnerable to valuation compression if growth disappoints. The stock's beta of 0.895 suggests lower volatility than the market, but its 1-year relative strength of -16.9% indicates persistent selling pressure. Competitive threats from smaller players in water treatment and AI cooling could erode market share. Regulatory risks around environmental standards and data center energy use could also impact operations. The CoolIT acquisition faces execution risk in a rapidly evolving AI infrastructure market.
Worst-Case Scenario: If the CoolIT integration fails to deliver expected synergies, revenue growth decelerates below 5%, and margins contract due to integration costs, the stock could fall to its 52-week low of $243.15, representing a 9.5% decline from the current price of $268.75. In a severe recession scenario, a drop to the analyst low target of $275 (2.3% upside) is possible, but a break below $243 would signal further downside to the $220 level, implying a 18% loss. The historical max drawdown of -20.31% suggests a worst-case loss of about 20% from current levels.
FAQ
The primary risk is integration of the CoolIT acquisition, which could weigh on margins and distract management. Financial risk includes a debt-to-equity ratio of 0.97, which could rise post-acquisition. Competitive risk comes from smaller players in water treatment and AI cooling. Macro risk includes a recession impacting industrial and hospitality demand, which could slow revenue growth below 5%. The stock's 1-year relative strength of -16.9% indicates persistent selling pressure, suggesting market skepticism.
The 12-month outlook includes a bull case (30% probability) with a target of $310-$345, driven by successful CoolIT integration and margin expansion. The base case (45% probability) targets $280-$320, assuming steady growth and stable margins. The bear case (25% probability) targets $243-$275, if integration fails or macro headwinds hit. The most likely scenario is the base case, with the stock reaching the analyst average of $319.43, implying 18.9% upside from the current price of $268.75.
ECL's trailing P/E of 35.8x is 63% above the specialty chemicals industry average of 22x, suggesting it is overvalued relative to peers. However, compared to its own 5-year history (range 24x-74x), the current multiple is near the midpoint, indicating it is fairly valued historically. The forward P/E of 28.7x implies the market expects 20% earnings growth, which is achievable if the CoolIT acquisition delivers. The premium is partially justified by superior margins (43.6% gross) and ROE (21.2%), but leaves little room for error.
ECL offers a compelling risk/reward for long-term investors, with 18.9% upside to the analyst average target of $319.43. However, the stock trades at a premium valuation (35.8x trailing P/E vs 22x industry) and faces integration risks from the $4.75 billion CoolIT acquisition. For investors with a 3-5 year horizon who believe in the AI cooling thesis, it could be a good buy, especially on pullbacks near the 52-week low of $243. Short-term traders may find better opportunities given the stock's range-bound behavior and underperformance vs the S&P 500.
ECL is better suited for long-term investment due to its steady growth, strong margins, and strategic pivot into AI cooling. The stock's beta of 0.895 indicates lower volatility than the market, making it a defensive holding. Short-term traders may find limited opportunities given the range-bound technicals and 1-year price decline of 0.4%. A minimum holding period of 3-5 years is recommended to allow the CoolIT acquisition to contribute and the premium valuation to be justified by earnings growth.
